UCLA Health launches telehealth genitourinary cancer genetics program

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

UCLA Health and the Department of Urology at UCLA have created a new telehealth cancer genetics program that will provide rapid access to high-quality genetic counseling and testing.

The program, which officially launches June 29, 2020, will focus on diagnosing hereditary kidney, bladder, testicular and prostate cancers. The program hopes to complement and expand on the work providers at the UCLA Jonsson Comprehensive Cancer Center have already developed.

There is a national shortage of genetic counselors, potentially impacting clinical outcomes of those who are diagnosed. In partnership with Genome Medical, this service will augment current efforts of UCLA genetic counselors to keep up with the rapid increase in new criteria for genetic testing.

Table of Contents

YOU MAY BE INTERESTED IN

Twenty years ago, the discovery of epidermal growth factor receptor mutations as drivers of tumorigenesis and viable targets for therapeutic intervention marked the beginning of a new era in lung cancer diagnosis and treatment. Since then, the field has made remarkable progress towards developing more effective targeted treatments and immunotherapies that have significantly improved patient outcomes and survival.

Login